| P50 | author | Alexander Klibanov | Q4719325 |
| | Richard J Price | Q89982952 |
| P2093 | author name string | Ji Song | |
| | G Wilson Miller | |
| | Alexander S Mathew | |
| | Caitleen A Copeland | |
| | Catherine M Gorick | |
| | Delaney G Fisher | |
| | E Andrew Thim | |
| | William J Garrison | |
| P2860 | cites work | Theoretical study on shear stress generated by microstreaming surrounding contrast agents attached to living cells | Q77732172 |
| | Gene therapy for Parkinson's disease | Q83053649 |
| | Sonoporation of endothelial cells by vibrating targeted microbubbles | Q83937257 |
| | Ultrasound-mediated targeted microbubble sonoporation of endothelial cells | Q83999613 |
| | Minireview: Biophysical Mechanisms of Cell Membrane Sonopermeabilization. Knowns and Unknowns | Q90331656 |
| | The relevance of skull density ratio in selecting candidates for transcranial MR-guided focused ultrasound | Q91735372 |
| | Zero TE MRI applications to transcranial MR-guided focused ultrasound: Patient screening and treatment efficiency estimation | Q93128679 |
| | "You Shall Not Pass"-tight junctions of the blood brain barrier | Q21129349 |
| | The blood-brain barrier: bottleneck in brain drug development | Q22336985 |
| | Facilitation of Drug Transport across the Blood-Brain Barrier with Ultrasound and Microbubbles | Q26781322 |
| | Drug and gene delivery across the blood-brain barrier with focused ultrasound | Q28080611 |
| | The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice | Q28253117 |
| | Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications | Q28297458 |
| | Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles | Q28468445 |
| | ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 | Q28588420 |
| | The blood-brain barrier/neurovascular unit in health and disease | Q29616335 |
| | Stroke Epidemiology and Risk Factor Management | Q30238611 |
| | Epidemiology of Brain Tumors | Q30244731 |
| | MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound | Q30252977 |
| | Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound | Q30277809 |
| | Mechanism of Low-Frequency Ultrasound in Opening Blood–Tumor Barrier by Tight Junction | Q50441989 |
| | Viability of endothelial cells after ultrasound-mediated sonoporation: Influence of targeting, oscillation, and displacement of microbubbles. | Q51226554 |
| | Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. | Q51242178 |
| | Microbubble oscillating in a microvessel filled with viscous fluid: A finite element modeling study. | Q51613045 |
| | Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound. | Q52691959 |
| | Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening. | Q55286921 |
| | MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain | Q57116018 |
| | Stroke | Q57312974 |
| | Drug transport across the blood-brain barrier | Q57677287 |
| | Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound | Q61135580 |
| | Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study | Q61445180 |
| | Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles | Q30312032 |
| | Biophysical insight into mechanisms of sonoporation | Q30361750 |
| | Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound. | Q30370894 |
| | Neural immune modulation and immunotherapy assisted by focused ultrasound induced blood-brain barrier opening | Q30374364 |
| | Cardiac Gene Expression Knockdown Using Small Inhibitory RNA-Loaded Microbubbles and Ultrasound. | Q30376315 |
| | Focused Ultrasound-Induced Neurogenesis Requires an Increase in Blood-Brain Barrier Permeability. | Q30376950 |
| | Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood--brain barrier opening in vivo. | Q30387126 |
| | Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus | Q30394725 |
| | State-of-the-art materials for ultrasound-triggered drug delivery | Q30409234 |
| | Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study | Q30416228 |
| | Stimulation of hippocampal neurogenesis by transcranial focused ultrasound and microbubbles in adult mice | Q30417568 |
| | Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy | Q30424484 |
| | Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle | Q30426977 |
| | Gene therapy of carcinoma using ultrasound-targeted microbubble destruction | Q30434291 |
| | Ultrasound-induced blood-brain barrier opening | Q30437732 |
| | Permeability assessment of the focused ultrasound-induced blood–brain barrier opening using dynamic contrast-enhanced MRI | Q30439286 |
| | In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice | Q30439400 |
| | Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles | Q30443197 |
| | Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. | Q30447306 |
| | Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller | Q30455962 |
| | Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency | Q30460006 |
| | Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier | Q30472787 |
| | Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium | Q30488665 |
| | Ultrasound-induced blood-brain barrier opening for drug delivery | Q30881449 |
| | The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis | Q33568457 |
| | Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia | Q33834648 |
| | Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits | Q33954300 |
| | Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model | Q34043432 |
| | Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis | Q34092793 |
| | Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 |
| | Gene therapy for central nervous system repair. | Q34348525 |
| | Convection-enhanced delivery of macromolecules in the brain | Q35091232 |
| | Clinical applications involving CNS gene transfer | Q35899850 |
| | Brain metastases: epidemiology and pathophysiology. | Q36282137 |
| | Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer's disease | Q37073099 |
| | Role of inflammation and its mediators in acute ischemic stroke | Q37312790 |
| | An immunological approach to cerebral ischemia (I). Immune cells and adhesion molecules | Q37373672 |
| | Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation. | Q37577170 |
| | Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound | Q37725032 |
| | In-vivo gene delivery by sonoporation: recent progress and prospects | Q38060228 |
| | Understanding ultrasound induced sonoporation: definitions and underlying mechanisms | Q38165638 |
| | Convection-enhanced delivery to the central nervous system | Q38268184 |
| | Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier | Q38288170 |
| | Sonoporation: Concept and Mechanisms | Q38612532 |
| | Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model | Q38703346 |
| | Estimating the true global burden of mental illness | Q38724785 |
| | Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease. | Q39033206 |
| | Membrane perforation and recovery dynamics in microbubble-mediated sonoporation. | Q39092368 |
| | Neuroinflammation in Neurodegenerative Disorders-a Review | Q39173756 |
| | Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases | Q39440179 |
| | Folate-conjugated gene-carrying microbubbles with focused ultrasound for concurrent blood-brain barrier opening and local gene delivery | Q39469955 |
| | Local delivery system of cytotoxic agents to tumors by focused sonoporation. | Q40175710 |
| | Genetic manipulation of brain endothelial cells in vivo | Q41238708 |
| | Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption | Q41674789 |
| | Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease | Q42177668 |
| | Acute Inflammatory Response Following Increased Blood-Brain Barrier Permeability Induced by Focused Ultrasound is Dependent on Microbubble Dose | Q43693994 |
| | Magnetic Enhancement of Stem Cell-Targeted Delivery into the Brain Following MR-Guided Focused Ultrasound for Opening the Blood-Brain Barrier | Q44516296 |
| | DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles | Q45869863 |
| | Ultrasound mediated destruction of DNA-loaded microbubbles for enhancement of cell-based therapies: new promise amidst a confluence of uncertainties? | Q45927710 |
| | Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation | Q46147948 |
| | Efficient, inducible Cre-recombinase activation in vascular endothelium. | Q46767104 |
| | Dynamics and mechanisms of intracellular calcium waves elicited by tandem bubble-induced jetting flow. | Q47215494 |
| | Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders | Q47615924 |
| | Numerical evaluation of the skull for human neuromodulation with transcranial focused ultrasound | Q47676739 |
| | Amyloid β Plaque Reduction With Antibodies Crossing the Blood-Brain Barrier, Which Was Opened in 3 Sessions of Focused Ultrasound in a Rabbit Model. | Q48098419 |
| | Demonstration of potential noninvasive ultrasound brain therapy through an intact skull | Q48486462 |
| | Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity | Q48655725 |
| | The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles | Q48938424 |
| | Power cavitation-guided blood-brain barrier opening with focused ultrasound and microbubbles | Q49852870 |
| | Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles | Q50250294 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P921 | main subject | blood–brain barrier | Q221694 |
| P304 | page(s) | 5644-5654 | |
| P577 | publication date | 2020-03-02 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Sonoselective transfection of cerebral vasculature without blood-brain barrier disruption | |
| P478 | volume | 117 | |